Synthesis of non-GMP small molecules, POP: 9/18/17-9/17/22
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSN261201700007I
- Awardee
-
Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 9 $4,217,353 obligated
Award facts
- Opportunity
-
- N02CM7700018 Solicitation number
- Synthesis of Non-GMP Small Molecules Award Notice · Posted Sep 14, 2017
- Synthesis of Non-GMP Small Molecules Award Notice · Posted Nov 23, 2016
- Combined order value
-
- $4,217,353 Current, with exercised options
- $5,649,056 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 54% used
- $7,777,665.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to Alchem Laboratories Corporation. The contract has a potential value of $7,777,665 and a period of performance from September 2017 to September 2022.
Under the contract, Alchem Laboratories Corporation provides non-good manufacturing practices synthesis of small molecules to support the National Cancer Institute's research efforts. Delivery orders have been placed for the synthesis of specific compounds, including 100 grams of (R)-N-(6-Chloro-4-((1-phenylethyl)amino)pyrido[3,4-d]pyrimidin-5-yl)methanesulfonamide with a value of $43,887.60 to be completed in October 2022. Other orders include the synthesis of up to ten sample compounds annually from September 2021 to September 2026, valued at $3.28 million. Work is performed in Alachua, Florida.
The original solicitation sought the non-good manufacturing practices synthesis of small molecules to advance the National Cancer Institute's cancer research mission. Delivery orders indicate the contract supports both discrete synthesis of specific compounds as well as ongoing continuity of supply for the National Cancer Institute's research programs. Placed orders demonstrate the prime contractor's performance of diverse small molecule syntheses from milligram to multi-gram quantities.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201700007I?
HHSN261201700007I was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on September 18, 2017.
How much is contract HHSN261201700007I worth?
Orders under HHSN261201700007I have obligated $4,217,353. Their combined potential value, with all options, is $5,649,056. HHSN261201700007I's own ceiling is $7,777,665.
How many orders have been placed under contract HHSN261201700007I?
9 orders have been placed under HHSN261201700007I, the latest on July 22, 2022.
Who can order from contract HHSN261201700007I?
HHSN261201700007I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HHSN261201700007I competed?
The extent of competition for HHSN261201700007I was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV